Vaxart Inc VXRT:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:59 PM EDT
0.71quote price arrow down-0.0023 (-0.3218%)
Volume
8,567
Close
0.7147quote price arrow up+0.0014 (+0.1963%)
Volume
1,831,640
52 week range
0.53 - 1.59
Loading...
  • Open0.75
  • Day High0.769
  • Day Low0.68
  • Prev Close0.7133
  • 52 Week High1.59
  • 52 Week High Date05/16/23
  • 52 Week Low0.53
  • 52 Week Low Date12/29/23

Key Stats

  • Market Cap124.259M
  • Shares Out173.86M
  • 10 Day Average Volume1.34M
  • Dividend-
  • Dividend Yield-
  • Beta0.68
  • YTD % Change24.77

KEY STATS

  • Open0.75
  • Day High0.769
  • Day Low0.68
  • Prev Close0.7133
  • 52 Week High1.59
  • 52 Week High Date05/16/23
  • 52 Week Low0.53
  • 52 Week Low Date12/29/23
  • Market Cap124.259M
  • Shares Out173.86M
  • 10 Day Average Volume1.34M
  • Dividend-
  • Dividend Yield-
  • Beta0.68
  • YTD % Change24.77

RATIOS/PROFITABILITY

  • EPS (TTM)-0.58
  • P/E (TTM)-1.22
  • Fwd P/E (NTM)-1.51
  • EBITDA (TTM)-74.723M
  • ROE (TTM)-97.94%
  • Revenue (TTM)7.379M
  • Gross Margin (TTM)5.38%
  • Net Margin (TTM)-1,117.56%
  • Debt To Equity (MRQ)11.12%

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date11/09/2012
  • Div Amount6.648
  • Split Date-
  • Split Factor-

Latest On Vaxart Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its development programs include pill vaccines designed to protect against norovirus...
Michael Finney Ph.D.
Chairman of the Board
Steven Lo
President, Chief Executive Officer, Director
Phillip Lee
Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer
Raymond Stapleton
Chief Technology Officer
Address
170 Harbor Way, Suite 300
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
MCRB
Seres Therapeutics Inc
0.9906+0.0816+8.9769%
COYA
Coya Therapeutics Inc
9.05+0.67+8.00%
CLLS
Cellectis SA
2.56UNCHUNCH
OMGA
Omega Therapeutics Inc
2.23-0.06-2.62%
SYRS
Syros Pharmaceuticals Inc
5.40+0.02+0.37%